| 000 | 01317 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512004610.0 | ||
| 264 | 0 | _c19900130 | |
| 008 | 199001s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKafiluddi, R | |
| 245 | 0 | 0 |
_aExtracellular magnesium and cardiotonic steroid toxicity in isolated myocardial preparations. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cDec 1989 |
||
| 300 |
_a1120-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArrhythmias, Cardiac _xchemically induced |
| 650 | 0 | 4 |
_aCa(2+) Mg(2+)-ATPase _xanalysis |
| 650 | 0 | 4 |
_aCardiac Glycosides _xtoxicity |
| 650 | 0 | 4 |
_aDigoxin _xtoxicity |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMagnesium _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aOuabain _xmetabolism |
| 650 | 0 | 4 |
_aRubidium _xpharmacokinetics |
| 650 | 0 | 4 |
_aSodium _xmetabolism |
| 700 | 1 | _aKennedy, R H | |
| 700 | 1 | _aSeifen, E | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 251 _gno. 3 _gp. 1120-7 |
|
| 999 |
_c2538214 _d2538214 |
||